(2) Meyer, W.: "An improved method of the Radical operation for carcinoma of the breast". Med Rec.1984; 46:746.
(3) Hellman, S. :"Natural history of small breast cancers". J Clin Oncol. 1994; 12: (10): 2229-2234.
(4) Fisher, B.: "Laboratory and clinical research in breast cancer-A personal adventure: The David A. Karnovsky Memorial Lecture. Cancer Res 1980; 40:3863-3874.
(5) Tabar, L., Fagerberg, G., Duffty, S.W., et al: "Update of the swedish two-county program of mammography screening for breast cancer". Radiol Clin North Am. 1992; 30: 187-210.
(6) Koscielny, S., Tubiana, M., Le, M.G. et al: "Breast cancer: relationship between the size of the primary tumor and the probability of metastatic dissemination. Br J Cancer. 1984; 49: 709-715.
(7) Tubiana, M., Koscielny, S.: "The natural history of breast cancer: Implications for a screening strateg. Int J Radiat Oncol Biol Phys. 1990; 19: 1117-1120.
(8) Rosen, P.P., Groshen, S., Saigo, P.E. et al: "A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J. Clin Oncol. 1989; 7(3): 355-366.
(9) Early Breast Cancer Trialists' Collaborative Group: Effects of Radiotherapy and Surgery in early breast cancer". N Engl J Med. 1995. 333 (22): 1444-1455.
(10) Early Breast Cancer Trialists´Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355: 1757-1770, 2000.
(11) Holland, R., Solke, H.J., Veling, M. et al: "Histologic multifocality of Tis, T1, T2 breast carcinoma. Implications for clinical trials of breast-conserving surgery". Cancer. 1985; 56: 979-990.
(12) De Vita VT, Hellman S and Rosemberg S. Cancer
Principles & Practice of Oncology. Lippincott Williams & Wilkins.
6ta. Edición, 2001.
(13) Fowble, B.: "Conservative surgery and radiation in the treatment of ductal carcinoma in situ and stage I - II breast cancer". 34th Annual Scientific Meeting American Society for Therapeutic Radiology and Oncology. 1992; 403: 1-39.
(14) Holland, R., Hendreiks, J., Verbeek, A. et al: "Extent, distribution and mamographic/histologic correlations of breast ductal carcinoma in situ". Lancet. 1990; 35: 519-522.
(15) Lagios, M. D.:"Ductal carcinoma in situ: Pathology and treatment". Surg Clin N America 1990; 70 (4): 853-871.
(16) Bradley S., Weaver, DW, Bovwman, DL: "Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome". Am Surgeon. 1990; 56: 428-432.
(17) Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999; 340: 1455.
(18) Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: finding from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998: 16:441.
(19) Julien J.P., Bijker N., Fentiman I.S., et al, Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III Trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000 Feb 12; 355 (9203): 528-33.
(20) Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ; Analysis of EORTC trial 10853. The European Journal of Cancer, Vol 36, Supplement 5, S65, Nº 120, 2000.
(21) Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for staging of cancer. J.B. Lippincott Company, Philadelphia. 1992.
(22) Wong JS, Harris JR: Importance of local tumour control in breast cancer. The Lancet Oncology 2: 11-17, 2001.
(23) NIH consensus conference. Treatment of early-stage breast cancer. JAMA. 1991; 265: 391-395.
(24) Arriagada, R., Lê, M., Rochard, F. and Geneviève Contesso for the Institute Gustave Roussy Breast Cancer Group: "Conservative Treatment versus Mastectomy in Early Breast Cancer: Patterns of failure with 15 Years of Follow-up Data". Journal of Clinical Oncology. 1996; 14, (5): 1558-1564.
(25) Fisher, B., Redmond, C. et al: " Eight-year results
of a randomized clinical trial comparing total mastectomy and lumpectomy
with or without irradiation the treatment of breast cancer". The New England
Journal of Medicine.1989; 320 (13): 822-828.
(26) Jacobson, J.A., Danforth, D.N., Cowan, K. et al. "Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer". N Engl J Med. 1995; 332 (14): 907-911.
(27) Veronesi, U., Banfi, A., Salvadori, B., Luini, A. et al: "Breast Conservation is the Treatment of Choice in Small Breast Cancer: Long-term Results of a Randomized Trial. Eur J Cancer. 1990; 26 (6): 668-670.
(28) Eberlein, T.J., Connolly, J.L., Schnitt, S.J. et al: "Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. Arch Surg. 1990; 125:771-777.
(29) Kurtz, J.M., Jacquemier, J., Amalric, R. et al: "Breast-conserving therapy for macroscopically multiple cancers. Ann Surg. 1991; 212: 38-44.
(30) Rutqvist, R.: "Radiation Therapy in the Primary Management of Early-Stage Breast Cancer". Recent Results in Cancer Research. Adjuvant Therapy of Breast Cancer V. Springer-Verlag Berlin Heidelberg. 1996; 241-250.
(31) Clark, R., McCulloch, P. et al. "Randomized Clinical Trial to Assess the Effectiveness of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cáncer". Journal of the National Cancer Institute.1992; 84 (9): 683-689.
(32) Harris JR, Lippman ME, Morrow M, et al: Disease of the breast. Philadelphia, PA, Lippincott-Raven, 1996, p. 159.
(33) Clark, R. M.; McCullough, P.B.; Levine, M.N.;
et al. Randomized clinical trial to
asses the effectiveness of breast irradiation following lumpectomy
and axillary
dissection for node-negative breast cancer. J. Natl. Cancer Inst. 84:
683-689, 1992.
(34) Fisher, B.; Redmond, C.; Poisson, R.; et al. Eight-year
results of
randomized clinical trial comparing total mastectomy and lumpectomy
with or
without irradiation in the treatment of breast cancer. N. Engl. J.
Med. 320: 822
828; 1989.
(35) Forrest, A.P.; Stewart, H.J.; Everington, D.; Prescott, R.J.; McArdle, C.S.; Harnett, A.N.; Smith, D.C.; George, W.D. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 348: 708-713, 1996.
(36) Liljegren, G.; Holmberg, L.; Adami, H.O.; et al. Sector resection with or without posoperative radiotherapy for stage I breast cancer: Five-year results of a randomized trial. J. Natl. Cancer Inst. 86: 717-722.1994.
(37) Fisher B., Dignam J., Wolmark N., et al. Lumpectomy
and radiation therapy for
the treatment of intraductal breast cancer: findings from National
Adjuvant Breast and
Bowel Project B-17. J. Clin Oncol. 1998 Feb; 16 (2): 441-52.
(38) Fisher B, Anderson S, Fisher E, et al: Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet 338: 327-331, 1991
(39) Haffty B, Reiss M, Beinfield M, et al: Ipsilateral
breast tumor recurrence as
predictor of distant disease: Implications for systemic therapy at
the time of local
relapse. J Clin Oncol. 14: 52-57, 1996.
(40) Whelan T, Clark R, Roberts R, et al: Ipsilateral breast tumor recurrence post-lumpectomy is predictive of subsequent mortality: Results from a randomized trial. Int J Radiat Oncol. Biol Phys 30: 11-16, 1994.
(41) A. Fortin, M. Karochelle, J. Laverdiere, S. Lavertu and D. Tremblay: Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radioteraphy. J Clin Oncol. 17: 101-109, 1999.
(42) Fisher B, Wickerham DL, Deutsch M, et al: Breast tumor recurrence following lumpectomy with and without breast irradiation: An overview of recent NSABP findings. Semin Surg Oncol. 8: 153-160, 1992
(43) R Arriagada, MD; H Mouriesse, B.S.; D. Sarrazin, M.D.; R.M. Clark, F.R.C.R., F.R.C.P. and G. Deboer, PhD. Radiotherapy alone in breast cancer. I Analysis of tumor parameters, tumor dose and local control: the experience of the Institute Gustave Roussy and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys Vol 11, pp. 1751-1757, 1985.
(44) Raditherapy & Oncology. Abstracts of the 15th Annual ESTRO Meeting. Viena Austria, 23-26 September, 1996. Vol. 40 (Suppl. 1), 1996.
(45) Horiot JC, Collette L, Fourquet A, Jager JJ, et al. Impact of a boost dose of 16 Gy on local control in patients with early breast cancer: The EORTC " boost versus no boost" trial. The European Journal of Cancer, Vol 36, Supplement 5, S93, Nº 251, 2000.
(46) Lichter, A.S., Fraass, B.A., Yanke, B.: "Treatment techniques in the conservative management of breast cancer". Seminars in Radiation Oncology. 1992; 2 (2):94-106.
(47) Strom EA and McNeese MD. Postmastectomy Irradiation:
Rationale for
treatment field selection. Seminars in Radiation Oncology. Vol. 9 Nº
3, 247-253, 1999.
(48) Donegan WL, Perez MC, Watson FR: A biostatistical
study of locally
recurrent breast carcinoma. Surg Gynecol Obstet 122: 529-540, 1966.
(49) Arriagada R, Rutqvist LE, Mattsson A, et al: Adequate
locoregional
treatment for early breast cancer may prevent secondary disemination
[see comments]. J Clin Oncol 13: 2869-2878, 1995.
(50) Rutqvist LE, Pettersson D, Johansson H: Adjuvant radiation therapy versus surgery alone in operable breast cancer: Long term follow-up of a radomized clinical trial. Radiother Oncol 26: 104-110, 1993.
(51) Recht A, Pierce SM, Aner A, et al: Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9:988-996, 1991.
(52) Halverson KJ, Taylor ME, Perez CA, et al: Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer [see comments]. Int Radiat Oncol Biol Phys 26: 593-599, 1993.
(53) Urban JA, Marjani MA: Significance of internal mammary lymph nodo metastases in breast cancer. Am J Roentgenol Radium Ther Nucl Med 111: 130-136, 1971.
(54) Bucalossi P, Veronesi U, Zingo L, et al: Enlarged mastectomy for breast cancer: Review of 1.213 cases. Am J Roentgenol Radium Ther Nucl Med 111: 119-122, 1971.
(55) Handley RS: Carcinoma of the breast. Ann R Coll Surg Engl 57: 59-66, 1975.
(56) Li KY, Shen ZZ: An analysis of 1.242 cases of extended radical mastectomy. Breast 10: 10-19, 1984.
(57) Arriagada, R., Le, M.G., Mouriesse, H. et al: "Long -term effect of internal mammary chain treatment. Results of a multivariate analysis of 1204 patients with operable breast cancer and positive axillary nodes". Radiother Oncol. 1988; 11: 213-222.
(58) Zucali R, Mariani L, Marubini E, et al: Early breast cancer: Evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 16: 1363-16366, 1998.
(59) Vicini FA, Horwitz EM, Lacerna MD, et al: The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int. J Radiat Oncol Biol Phys 39: 1069-1076, 1997.
(60) Mehta K, Haffty BG: Long-term autcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 35: 679-685, 1996.
(61) Recht A, Pierce SM, Aner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early stage breast carcinoma. J Clin Oncol 1991; 9: 988
(62) Hafty BG, McKhann C, Beinfield M, Fischer D, Fischer JJ. Breast conservation therapy without axillary dissection. A rational treatment strategy in selected patients. Arch Surg 1993; 128: 1315.
(63) Wazer DE, Erban JK, Robert NJ, et al. Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 1994; 74: 878.
(64) Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674.
(65) Cabanes P, Salmon R, Vilcoq J et. al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992; 339: 1245.
(66) Greco C, Orecchia R, Valesi G et al. Randomized clinical trial on the role of axillary dissection lesion < 1 cm. [Abstract]. Int J Radiat Oncol Biol Phys 1998; 42: 250.
(67) Arriagada R, Rutqvist LE, Mattsson A, et al: Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol. 13: 2869 - 2878, 1995.
(68) Koscielny S, Tubiana M. The link between local
recurrence and distant
metastasis. Int. J. Radiat. Oncol. Biol. Phys. 1999; 43: 11-24.
(69) Whelan TJ, Julian J, Wright J, Jadad AR, Levine
ML, Does locoregional radiation therapy improve survival in breast cancer?
A meta-analysis. J Clin Oncol. 200; 18:1220-29.
(70) Cuzick, J., Stewart, H., Rutqvist, L. et al: "Cause-Specific mortality
in long-term survivors of breast cancer who participed in trials of radiotherapy".
J. Clin Oncol. 1994; 12 (3): 447-453.
(71) Kurtz JM. Radiotherapy for early breast cancer: was a comprehensive overview of trials needed? The Lancet 355: 1739-1740, 2000.
(72) Hojris I, Andersen J, Overgaard M and Overgaard J.: Late treatment-related morbidity in breast cancer patients randomized to posmastectomy radiotherapy and systemic treatment versus systemic treatment alone. Acta Oncologica 390: 355-372, 2000.
(73) Overgaard M, Hanse PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl. J. Med. 1997; 337: 949-955.
(74) Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. N Engl J Med 1997,337: 956-962.
(75) Abrahamsen AF, Loge JH, Hannisdal E, et al: Late medical sequelae after therapy for supradiaphragmatic Hodgkin´s disease. Acta Oncologica 38: 511-515, 1999.
(76) Cuzick J, Stewart H, Rutqvist L, et al: Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994; 12: 447-53.
(77) Hojris I, Overgaard M, Christensen J, et al: Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82C randomised trials. Lancet 354: 1425 - 1430, 1999.
(78) Das I J, Cheng EC, Freedman G, Fowble B: Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer. Int J Radiat Oncol Biol Phys1998; 42: 11-1998.
(79) Gyenes G, Gagliardi G, Lax I, Fornander T, Rutqvist L E: Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 15: 1348 - 1353, 1997.
(80) Overgaard M, Jensen MB, Overgaard J. Et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 1999; 353: 1641-1648.
(81) Ragaz J, Jackson S, Le N, et al. Postmastectomy radiation (RT) outcome in node (N) positive breast cancer patients among N 1-3 versus N4+ subset: impact of extracapsular 20 spread (ES). Update of the British Columbia randomized trial. Proc. ASCO 1999; 18:73a abstr 274.
(82) Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N. Eng. J. Med. 1989; 320: 822-828.
(83) Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 1995; 333: 1456-1461.
(84) De Steene JV, Soete G, Storme G: Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiotherapy & Oncology 55 (2000) 263-272.
(85) Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR: Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol. Biol Phys 1991; 21: 355-360.
(86) Arriagada R and Lê MG: Adjuvant Radiotherapy in Breast Cancer. Acta Oncologica 39: 295-305, 2000.
(87) Wondergem J, Leer J.W.H, Kruse J.J.C.M., Noordijk: Radiobiological aspects of radiation-induced heart disease. Radiotherapy & Oncology 56: S88, 2000.
(88) Corn BW, Trock Bj, Goodman RL. Irradiation-related ischemic heart disease: J Clin Oncol. 1990; 8: 741-750.
(89) Stewart JR, Fajardo LF, Gillette SM, et al. Radiation injury to the heart. Int J Radiat Oncol. Biol Phys 1995; 31: 1205-1211.
(90) Gustavsson A, Bendahl P, Cwikiel M, Eskilsson J, et al. No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer. Int J Radiat Oncol. Biol Phys 43: 745-754, 1999.
(91) Paszat L, Mackillop W, Groome P, Boyd C, Schulze K, Holowaty E: Mortality form myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology and end-results cancer registries. J Clin Oncol. 16: 2625-2631, 1998.
(92) Rutqvist LE, Lax I, Fornander T, et al: Cardiovascular mortality in a randomized trial adjuvant radiation therapy versus surgery alone in breast cancer. Int J Radiat Oncol. Biol Phys 22: 887-896, 1992.
(93) Rutqvist LE, Johansson H: Mortality by laterality of the primary tumours among 55,000 breast cancer patients from the Swedish cancer registry. Br J Cancer 61: 866-868, 1990.
(94) Fuller SA, Haybittle JL, Smith REA, et al: Cardiac doses in post-operative breast irradiation. Radiother Oncol. 25: 19-24, 1992.
(95) Rutqvist LE, Liedberg A, Hammar N, Dalberg K: Myocardial infarction among women with early-stage breast cancer treatment with conservative surgery and breast irradiation. Int J Radiat Oncol. Biol Phys 40: 359 - 363, 1998.
(96) Lu H, Cash E, Chen MH, Chin L, Manning Warren, Harris J, Bornstein B: Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: A CT study. Int J Radiat Oncol. Biol Phys 47: 895-904, 2000.
(97) Nixon AJ, Manola J, Gelman R, et al: No long -term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 16: 1374 - 1379, 1998.
(98) Rutqvist LE: Controversial issues in Adjuvant Systemic Therapy of early breast cancer. Acta Oncologica 37: 421 - 430, 1998.
(99) Swain S, Whaley FS, Gerber MC, Weisberg S, York M, et al: Cardioproteccion with Dexrazoxane for Doxorubicin containing therapy in advanced breast cancer. J Clin Oncol. 15: 1318-1332, 1997.
(100) Levine MN, Bramwell VH, Pritchard K, Norris BD, et al: Randomized trial of intensive Cyclophosphamide, Epirubicin, and Fluorouracil Chemotherapy compared with Cyclophosphamide, Methotrexate, and Fluorouracil in premenopausal women with node-positive breast cancer. J Clin Oncol. 16: 2651-2658, 1998.
(101) Billingham ME, Bristow MR, Glabstein E, et al: Adriamycin cardiotoxicity: Endomyocardial biopsy evidence of enhancement by irradiation. Am J Surg Pathol 1:17-23, 1977.
(102) Shapiro CL, Hardenbergh PH, Gelman R, et al:
Cardiac effects of adjuvant
Doxorubicin and radiation therapy in breast cancer patients. J Clin
Oncol. 16: 3493
3501, 1998.
(103) Steinherz LJ and Yahalom J: Toxicity. Adverse
Effects of treatment in Cancer
Principles E Practice of Oncology. De Vita V, Hellman S, Rosenberg
S., pp 2739
2756, 1997.
(104) Howard A. Burris III et al: Docetaxel (Taxotere) in the treatment of cancer. Seminars in Oncology 27: 3-10, 2000.
(105) Perez CA and Taylor ME: Breast: Stage Tis, T1,
and T2 Tumors in Principles
and Practice of Radiation Oncology. Carlos A. Perez and Luther W. Brady,
pp.1269
1414, 1998.
(106) Taylor ME, Perez CA. Breast cancer treatment guidelines. Mallinckrodt Institute of Radiology Radiation Oncology Center. pp. 1-114, 1999.
(107) Gardner, Gray, O´Rahilly. Vasos, drenaje linfático y mama. En Anatomía de Gardner. Quinta Edición. pp101-108, 1989.
(108) Gardner, Gray, O´Rahilly. Pared torácoca, diafragma y mediatino. En Anatomìa de Gardner. Quinta Edición. pp 305-319, 1989.